Loading memory…
Loading memory…
Patent portfolio assigned to Sensill (verified via public assignee records). Estimated patent count: 2. Point-of-care non-invasive MedTech (Concord, CA) using VOC analysis to identify/quantify microbes in skin/wound infections. Pre-revenue, early-stage; no named customers or clear direct competitors found. Patents assigned to SENSILL, INC: US20230233193A1 and EP4240228A1 ('Devices, methods, and systems to collect, store, and analyze chemical substances') — at least 2 patent-family filings.